Janelle Lennie, Ph.D.

Research Scientist I

Janelle joined Metrum Research Group in June of 2012. She was accepted into the Biomedical Engineering Ph.D. program at the University of Connecticut in 2014, with support and academic advisement through Metrum Institute, and worked part-time as a Research Associate at Metrum Research Group while pursuing her Ph.D. Janelle successfully defended her dissertation titled “Assessment of Early Decision-Making Methods in Duchenne Muscular Dystrophy Clinical Trials: A Bayesian Modeling & Simulation Approach to Orphan Drug Development” in November of 2020, then began a Research Scientist I position at Metrum.

Recent publications by this scientist

Latent process model of the 6-minute walk test in Duchenne muscular dystrophy

January 30, 2020

Lennie, J.L., Mondick, J.T. & Gastonguay, M.R. Latent process model of the 6-minute walk test in Duchenne muscular dystrophy. J Pharmacokinet Pharmacodyn (2020).

View More

A latent variable disease progression model for Duchenne muscular dystrophy

October 9, 2018

Hajjar J. Poster presented at 2018 American Conference on Pharmacometrics (ACoP9). San Diego, CA. 9 Oct 2018. Abstract #T-011.

Download PDF

Population pharmacokinetic modeling of enzyme replacement therapy ATB200 and pharmacological chaperone AT2221 in adult patients with Pompe Disease and simulation to predict adolescent exposures

September 28, 2018

Hajjar J. Poster presented at 2018 Annual Meeting of the American College of Clinical Pharmacology. Bethesda, MD. 23 Sep 2018.

Download PDF